Insulet | PODD - EPS Earnings Per Share


Insulet reported $1.99 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 1.99 1.64 1.24 Nov/04
FY2026Q2 Jun/2026 1.66 1.46 1.17 Aug/05
FY2026Q1 Mar/2026 1.42 1.2 1.02 May/06
FY2025Q4 Dec/2025 1.44 1.46 1.15 Feb/18
FY2025Q3 Sep/2025 1.24 1.14 0.90 Nov/06




Eps Change Date
Abbott USD 0.53 0.78 Sep/2026
Align Technology USD 2.8 0.16 Sep/2026
AtriCure USD 0.17 0.01 Sep/2026
Baxter International USD 0.58 0.02 Sep/2026
Becton, Dickinson and Co. USD 2.52 0.71 Sep/2026
Boston Scientific USD 0.73 0.13 Sep/2026
Cardinal Health USD 2.65 0.05 Sep/2026
Cooper Companies USD 2.24 1.2 Jun/2026
Dexcom USD 0.73 0.03 Sep/2026
Edwards Lifesciences USD 0.8 0.02 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Globus Medical USD 1.23 0.11 Sep/2026
ICU Medical USD 2.44 0.07 Sep/2026
Inogen USD -0.25 0.01 Sep/2024
Insulet USD 1.99 0.33 Sep/2026
Integra LifeSciences USD 0.6 0.04 Sep/2026
J&J USD 2.7 0.2 Sep/2026
Medtronic USD 1.45 0.1 Jun/2026
Merit Medical Systems USD 1.12 0.07 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Solventum Corp USD 1.45 1.1 Sep/2026
Stryker USD 3.52 0.17 Sep/2026
Tandem Diabetes Care USD -0.1 0.21 Sep/2026
Teleflex USD 2.63 0.87 Sep/2026
West Pharmaceutical Services USD 2.66 0.29 Sep/2026
Zimmer Biomet Holdings USD 1.9 0.17 Sep/2026